|
1 |
Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood
Intest Res.2022;20(1):11-30. Published online 2021 April 15
DOI: http://dx.doi.org/10.5217/ir.2020.00155
|
|
2 |
Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood
Intest Res.2022;20(1):64-71. Published online 2021 February 3
DOI: http://dx.doi.org/10.5217/ir.2020.00100
|
|
3 |
Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
Jong Won Seo, Eun Soo Kim, Man-Hoon Han, Young Oh Kweon
Intest Res.2021;19(2):247-251. Published online 2020 July 2
DOI: http://dx.doi.org/10.5217/ir.2020.00016
|
|
4 |
NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
Katsuyoshi Matsuoka
Intest Res.2020;18(3):275-281. Published online 2020 June 3
DOI: http://dx.doi.org/10.5217/ir.2020.00002
|
|
5 |
Prevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn’s disease who turned out to possess homozygous mutations in NUDT15 R139C
Jaewoan Bae, Byung-Ho Choe, Ben Kang
|
|
6 |
Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease
Jee Hyun Kim, Ji Won Kim
|
|
7 |
Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide
Jina Yeo, Hyun Sun Woo, Sang Min Lee, Yoon Jae Kim, Kwang An Kwon, Dong Kyun Park, Jung Ho Kim, Kyoung Oh Kim, Jun-Won Chung
Intest Res.2017;15(4):529-534. Published online 2017 October 23
DOI: http://dx.doi.org/10.5217/ir.2017.15.4.529
|
|
8 |
Thiopurine S-Methyltransferase Polymorphisms in Korean Dermatologic Patients
Minseok Lee, Jimyung Seo, Dongsik Bang, Do Young Kim
Ann Dermatol.2017;29(5):529-535. Published online 2017 August 25
DOI: http://dx.doi.org/10.5021/ad.2017.29.5.529
|
|
9 |
Periprostetic Joint Infection Caused by Salmonella: Case Reports of Two Azathioprine and Prednisolone Induced-immunocompromised Patients
Mehmet Ekinci, Serkan Bayram, Turgut Akgül, Mehmet Ersin, Önder Yazicioğlu
Hip Pelvis.2017;29(2):139-144. Published online 2017 June 2
DOI: http://dx.doi.org/10.5371/hp.2017.29.2.139
|
|
10 |
Adult-Onset Asthma and Periocular Xanthogranuloma in a 75-Year-Old Man
Seung Wan Nam, Ju-Hyang Lee, Kyung In Woo, Yoon-Duck Kim
|
|
11 |
Clinical characteristics and treatment outcomes of primary autoimmune hemolytic anemia: a single center study from South India
Raghuveer Prabhu, Renjitha Bhaskaran, Veena Shenoy, Rema G, Neeraj Sidharthan
Blood Res.2016;51(2):88-94. Published online 2016 June 23
DOI: http://dx.doi.org/10.5045/br.2016.51.2.88
|
|
12 |
A Case of Azathioprine Induced Warfarin Resistance in Behçet's Disease
Sung Ryeol Kim, Dong Woo Leem, Il Joo Moon, Beom Seok Koh, Myung Hee Chang, Jongha Yoo, Hee Chul Yang, Chan Hee Lee
J Rheum Dis.2015;22(4):242-245. Published online 2015 October 31
DOI: http://dx.doi.org/10.4078/jrd.2015.22.4.242
|
|
13 |
Differences in the Adverse Effects of Azathioprine between Inflammatory Bowel Disease and Autoimmune Hepatitis in Korean Patients
Yoo Jin Lee, Wang Yong Choi, Kyung Sik Park, Yun Jung Kim, Kwang Bum Cho, Eun Soo Kim, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang
|
|
14 |
Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
Mi Jin Kim, Soo Youn Lee, Yon Ho Choe
Yonsei Med J.2014;55(5):1289-1296. Published online 2014 July 18
DOI: http://dx.doi.org/10.3349/ymj.2014.55.5.1289
|
|
15 |
A Case of Pleomorphic Liposarcoma in a Patient with Crohn's Disease Taking Azathioprine
Soo Min Ahn, Seong O Suh, Yu Mi Oh, Chang Yong Yun, Hyoung Hun Sim, Chae A Park, Cheol Min Song, Ji Yoon Bae
|
|
16 |
Successful Azathioprine Treatment with Metabolite Monitoring in a Pediatric Inflammatory Bowel Disease Patient Homozygous for TPMT*3C
Mi-Na Lee, Hye In Woo, Yoo Min Lee, Ben Kang, Jong-Won Kim, Yon Ho Choe, Soo-Youn Lee
Yonsei Med J.2013;54(6):1545-1549. Published online 2013 October 1
DOI: http://dx.doi.org/10.3349/ymj.2013.54.6.1545
|
|
17 |
Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
Ji Young Chun, Ben Kang, Yoo Min Lee, Soo Youn Lee, Mi Jin Kim, Yon Ho Choe
|
|
18 |
How Should Azathioprine Be Dosed in Crohn's Disease? A Novel Strategy of Maximum Dose-titration Based on the Lower Limit of Leukocyte Count and Tolerability
Chang Sup Lim, Won Moon, Seun Ja Park, Moo In Park, Jeong Moon Choi, Jae Hoon Yoo, Jong Bin Kim, Jun Sik Lee
|
|
19 |
Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
Mi Jin Kim, Yon Ho Choe
|
|
20 |
The Association between the Therapeutic Agent and the Compliance of the Patients with Inflammatory Bowel Diseases
Yun-Seong Kang, So Young Kim, Min Ho Jo, Hyoun Woo Kang, Jun Kyu Lee, Yun Jeong Lim, Moon Soo Koh, Jin Ho Lee, Chang Hun Yang, Jae Hak Kim
|
|